SCMP BusinessAI 繁中編譯21/9 18:00 (HKT)
分析師:美國限制威脅消退 中國生物科技交易料迎「高潮」
分析師預期，中美生物科技交易將蓬勃發展，因為華府據報傾向放棄全面限制，在北京為該行業推出雄心勃勃的五年規劃後，此舉將為中國醫療保健企業帶來重大提振。中美之間的對外授權交易將會
由 AI 自動翻譯自英文原文（保留香港新聞術語規範）
英文原標題：Expect ‘high tide’ of Chinese biotech deals as threat of US curbs fades: analysts
英文原摘要：US-China biotech deals are expected to thrive because Washington is reportedly leaning away from sweeping restrictions, according to analysts, giving Chinese healthcare firms a major boost following Beijing’s ambitious five-year plan for the sector. Out-licensing deals between China and the US would
HK24H 僅展示標題與短摘要（由 AI 編譯自英文），全文版權歸 SCMP Business 所有。